ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10501 | Rec_0010506 | Zinc finger CCCH-type antiviral protein 1 |
MADPGVCCFITKILCAHGGRMTLEELLGEIRLPEAQLYELLETAGPDRFVLLETGGQAGITRSVVATTRARVCRRKYCQRPCDSLHLCKLNLLGRCHYAQSQRNLCKYSHDVLSEQNFQILKNHELSGLNQEELACLLVQSDPFFLPEICKSYKGEGRKQTCGQPQPCERLHICEHFTRGNCSYLNCLRSHNLMDRKVLTIMREHGLSPDVVQNIQDICNNKHARRNPPGTRAAHPHRRGGAHRDRSKSRDRFLHNSLEFLSPVVSPLGSGPPSPDVTSCKDSLEDVSVDVTQKFKYLGTHDRAQLSPVSSKAAGVQGPSQMRASQEFSEDGNLDDIFSRNRSDSSSSRASAAKVAQRNEAVAMKMGMEVKGKKEAPDIDRVPFLNSYIDGVTMEKASVSGIPGKKFTANDLENLLLLNDTWKNVAKPQDLQTTGRITDSGQDKAFLQNKYGGNPVWASASTHNAPNGSSQIMDETPNVSKSSTSGFAIKPAIAGGKEAVYSGVQSPRSQVLAVPGEATTPVQSNRLPQSPLSSSSHRAAASGSPGKNSTHTSVSPAIESSRMTSDPDEYLLRYILNPLFRMDNHGPKEICQDHLYKGCQQSHCDRSHFHLPYRWQMFVYTTWRDFQDMESIEQAYCDPHVELILIENHQINFQKMTCDSYPIRRLSTPSYEEKPLSAVFATKWIWYWKNEFNEYIQYGNESPGHTSSDINSAYLESFFQSCPRGVLPFQAGSQKYELSFQGMIQTNIASKTQRHVVRRPVFVSSNDVEQKRRGPE |
Rattus norvegicus [Animal] |
Antiviral, Replication inhibitor, Anti-EBOV, Anti-MARV |
Ebola virus (EBOV)/Marburg virus (MARV) |
- | - |
17182693 | - |
YES |
| 10502 | Rec_0010507 | Unnamed |
RRWWRRFRR |
not reported [other] |
Cell-penetrating, Drug delivery |
cell membrane; drug delivery |
- | - |
34478499 | - |
NO |
| 10503 | Rec_0010508 | Hymenochirin-4B |
IKIPAFVKDTLKKVAKGVISAVAGALTQ |
Hymenochirus boettgeri [Animal] |
Antimicrobial,Antibacterial |
Enterococcus faecium VanA R39 [ |
128 μg/mL | MIC |
31102497 | - |
YES |
| 10504 | Rec_0010509 | Hainantoxin-VII |
ECRYWLGTCSKTGDCCSHLSCSPKHGWCVWDWTFRK |
Selenocosmia hainana [Animal]; Haplopelma hainanum [Animal]; Ornithoctonus hainana [Animal] |
Toxin |
- |
- | - |
- | - |
NO |
| 10505 | Rec_0010510 | CAP18 [L17D] |
GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 25922 |
- | - |
30245684;29852015 | - |
NO |
| 10506 | Rec_0010511 | Esculentin-2P (Frogs, amphibians, animals) |
GFLSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC |
Lithobates pipiens [Animal] |
Antiviral, Anti-FV3, Entry inhibition |
Frog Virus 3 |
500 μM | % inhibition |
11601906 | - |
YES |
| 10507 | Rec_0010512 | D16W-N23 (single amino acid substitution) |
GILDTLKQFAKGVGKWLVKGAAQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Eshchericia coli |
25 μg/mL | MIC |
12199716 | - |
YES |
| 10508 | Rec_0010513 | ARF(1-37) |
MVRRFLVTLRIRRACGPPRVRVFVVHIPRLTGEWAAP |
Homo sapiens [Animal] |
Cell-penetrating peptide |
MCF-7; MDA MB 231 |
- | Fluorescence-based uptake assay |
17984975 | - |
YES |
| 10509 | Rec_0010514 | Unnamed |
SFLTSFKDMAIKVAKDAGVNILNTISCKISKTC |
not reported [other] |
Antimicrobial |
- |
- | - |
22467909 | - |
NO |
| 10510 | Rec_0010515 | M-lycotoxin-Ls3b (M-LCTX-Ls3b) (Lycocitin-2) |
GRLQAFLAKMKEIAAQTL |
Lycosa singoriensis [Animal] |
Antimicrobial, Antifungal, Anti-Candida, Anti-Gram-negative, Anti-Gram-positive, Non-hemolytic |
Staphylococcus aureus |
- | - |
14991689 | - |
YES |
| 10511 | Rec_0010516 | Coagulation factor VIIa Recombinant Human |
ANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP |
Homo sapiens [Animal]; Mus musculus [Animal]; Bos taurus [Animal] |
Coagulation factor replacement, Enzyme replacement |
- |
- | - |
- | - |
NO |
| 10512 | Rec_0010517 | Lysozyme (EC 3.2.1.17) |
MNPTLRNKLVGAIVGGSGAISIAAVMLGNADGLEGRRYYAYQDVVGVWTVCDGHTGADIRRGHRYTDKECDNLLKADLRKVANSIDPLIKVRIPEPTRAALYSFTYNVGSGAFASSTLLKKLNAGDMPGACKELQRWTYAGGKQWKGLITRREIEREVCEWGQK |
Enterobacter cancerogenus [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 10513 | Rec_0010518 | 13(derived from FIV envelope glycoprotein ) |
GGKMLYNKVTKQLSYCTDPL |
synthetic construct [Synthetic] |
Antimicrobial, Antiviral |
- |
- | - |
8661378 | - |
YES |
| 10514 | Rec_0010519 | Lysozyme |
MDAAVTPDPLQIAATQLVEPFEGFSAEPYRDPGGVWSIGYGSTTDAWGNPVTADTPAISQADALALVERDLAAAQNVVSAAVFVPLDANQQAALIDFIYNVGAGNFYRSTLLALLNQGDYQGAAAQFVRWDYAAGVVLPGLLRRREAEAALFSLDQASLAKQDA |
Acidiphilium rubrum [Animal] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic, Non-ribosomal |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 10515 | Rec_0010520 | Unnamed |
GLLKKWLKKWKEFKRIVGY |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Enterococcus faecalis M6534 |
256 μg/mL | MIC |
24269514 | - |
YES |
| 10516 | Rec_0010521 | Unnamed |
ICCNPACGPKYSC |
not reported [other] |
Miscellaneous |
- |
- | - |
22058133 | - |
NO |
| 10517 | Rec_0010522 | beta-defensin 109-like |
MRLHVLFFMLLFLTLLSPVRSGLASGENHCLNLSGVCRRDICKMTEDQIGACKRRWVCCRAWWILIPVPTPVIYSDYQEPLKPKLK |
Vulpes vulpes [Animal] |
Antimicrobial, Antibiotic, Defensin, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 10518 | Rec_0010523 | Lysozyme g (EC 3.2.1.17) |
MGNGNIMDVETTGASEKTARQDQLDYGGVRASHTMAKTDSGRMEKYKSIINVVGRKYDIEPALIAAIISRESRAGNVLHDGWGDYDRNRGAYNAWGLMQVDVNPSGGGHTAKGAWNSEEHLCQGTEILVYFLNRIRNKFPSWTSEQQLKGAIASYNTGDGRVNSYENVDERTTGKDYSNDVVARAQWYKTKGGF |
Amphiprion percula [Animal] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 10519 | Rec_0010524 | Scapularisin-3 |
AFGCPFDQGTCHSHCRSIRRRGRRCASFAKRTCTCYQK |
Ixodes scapularis [Animal] |
Antifungal |
- |
- | - |
25443032 | - |
YES |
| 10520 | Rec_0010525 | Unnamed |
FAKALKALLKALKAL |
not reported [other] |
Anticancer |
- |
- | - |
- | - |
NO |